NASDAQ · ASTH
Astrana Health, Inc.
$36.62-$0.05 (-0.14%)
Astrana Health, Inc.’s quoted price sits in the upper half of its reported 52-week range, 29.03% below the high.
Loading market information…
OTC · SYRA · USD
Stock price, earnings
Quote as of Oct 29, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Syra Health Corp. Class A Common Stock’s quoted price sits in the upper half of its reported 52-week range, 36.43% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Syra Health Corp. Class A Common Stock’s next earnings report is currently expected on Nov 3, 2026, with estimated earnings per share of -$0.09. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Syra Health Corp. Class A Common Stock’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Syra Health Corp. is a U.S.-based healthcare services company offering a diverse portfolio of solutions. Their core offerings span health education, population health management, behavioral and mental health support, healthcare workforce solutions, and digital health advancements. Within health education, the company provides medical communications, patient-focused learning programs, and professional training. Its population health management segment features analytics-as-a-service, epidemiological studies, and health equity analysis tools. Additionally, Syra Health is actively developing "Syrenity," an on-demand telehealth platform specifically designed for mental health services. The firm further extends its reach through healthcare staffing provisions and comprehensive digital health solutions. These digital solutions encompass digital transformation initiatives, cloud and cybersecurity services, artificial intelligence applications, patient engagement tools, and various health-related mobile applications. Syra Health serves a broad spectrum of clients, including mental health facilities and organizations, government entities, integrated health networks, managed care organizations, and pharmaceutical manufacturers. Established in 2020, the company's headquarters are located in Carmel, Indiana.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 11:08 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
| Q1 2025 |
|---|
| May 8, 2025 |
| -$0.04+78.95% vs estimate |
| $1.75M+24.97% vs estimate |
| Q4 2024 | Mar 11, 2025 | -$0.16-128.57% vs estimate | $1.77M-19.72% vs estimate |
|---|
| Q3 2024 | Oct 29, 2024 | -$0.06+71.43% vs estimate | $1.60M-20.48% vs estimate |
|---|
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$36.62-$0.05 (-0.14%)
Astrana Health, Inc.’s quoted price sits in the upper half of its reported 52-week range, 29.03% below the high.
$210.10-$2.53 (-1.19%)
Nutex Health, Inc.’s quoted price sits in the upper half of its reported 52-week range, 7.1% below the high.
$3.31-$0.10 (-2.93%)
DarioHealth Corp.’s quoted price sits in the lower half of its reported 52-week range, 77.59% below the high.
$4.20+$0.17 (+4.22%)
P3 Health Partners Inc.’s quoted price sits in the lower half of its reported 52-week range, 75.13% below the high.
$1.94+$0.02 (+0.78%)
HealthLynked Corp.’s quoted price sits in the lower half of its reported 52-week range, 70.15% below the high.
$6.30-$0.13 (-2.02%)
Healthcare Triangle, Inc.’s quoted price sits in the lower half of its reported 52-week range, 99.82% below the high.
$1.92$0.00 (0.0%)
VSee Health, Inc.’s quoted price sits in the lower half of its reported 52-week range, 98.0% below the high.
$0.01-$0.00 (-7.79%)
Nexteligent Holdings, Inc.’s quoted price sits in the lower half of its reported 52-week range, 51.67% below the high.
